The estimated Net Worth of Adam Tomasi is at least $9.02 Миллион dollars as of 31 August 2021. Adam Tomasi owns over 64,148 units of Allakos Inc stock worth over $129,544 and over the last 6 years he sold ALLK stock worth over $648,978. In addition, he makes $8,238,770 as President и Chief Operating Officer at Allakos Inc.
Sign up
Adam Tomasi ALLK stock SEC Form 4 insiders trading
Adam has made over 8 trades of the Allakos Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 64,148 units of ALLK stock worth $276,478 on 31 August 2021.
The largest trade he's ever made was exercising 64,148 units of Allakos Inc stock on 31 August 2021 worth over $276,478. On average, Adam trades about 10,959 units every 9 days since 2018. As of 31 August 2021 he still owns at least 212,368 units of Allakos Inc stock.
You can see the complete history of Adam Tomasi stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Adam Tomasi biography
Dr. Adam Tomasi Ph.D. serves as President, Chief Operating Officer of the Company. Dr. Tomasi previously served as our Chief Financial Officer from April 2017 and as Secretary from November 2017 until August 2019. Dr. Tomasi is also on the board of directors of Attune Pharmaceuticals, a private biotechnology company. From August 2013 to January 2015, Dr. Tomasi served as Senior Vice President, Corporate Development of ZS Pharma, and from February 2015 to March 2017, he served as Chief Scientific Officer and Head of Corporate Development of ZS Pharma. Previously, Dr. Tomasi was a Principal at Alta Partners, where he was involved in the funding and development of notable medical technology and life science companies including Chemgenex, Excaliard, Lumena Pharmaceuticals, Achaogen, Immune Design, Allakos and ZS Pharma. Prior to joining Alta Partners, Dr. Tomasi was in the Harvard-MIT Biomedical Enterprise Program where he completed internships as an equity analyst at Lehman Brothers and at MPM Capital. Dr. Tomasi also previously worked as a medicinal chemist with Gilead Sciences and Cytokinetics, where he helped create the cardiovascular drug CK-1827452, which was licensed to Amgen. Dr. Tomasi holds a B.S. in Chemistry from the University of California, Berkeley, an MBA from the Massachusetts Institute of Technology Sloan School of Management and a Ph.D. in Chemistry from the University of California, Irvine.
What is the salary of Adam Tomasi?
As the President и Chief Operating Officer of Allakos Inc, the total compensation of Adam Tomasi at Allakos Inc is $8,238,770. There are 1 executives at Allakos Inc getting paid more, with Robert Alexander having the highest compensation of $12,559,300.
How old is Adam Tomasi?
Adam Tomasi is 50, he's been the President и Chief Operating Officer of Allakos Inc since 2019. There are 8 older and 1 younger executives at Allakos Inc. The oldest executive at Allakos Inc is Steven James, 62, who is the Independent Director.
What's Adam Tomasi's mailing address?
Adam's mailing address filed with the SEC is 825 INDUSTRIAL ROAD, SUITE 500, , SAN CARLOS, CA, 94070.
Insiders trading at Allakos Inc
Over the last 6 years, insiders at Allakos Inc have traded over $246,100,922 worth of Allakos Inc stock and bought 5,181,222 units worth $35,384,176 . The most active insiders traders include Paul Edward Walker, Group, Llc Green Jeremy Red... и Daniel Janney. On average, Allakos Inc executives and independent directors trade stock every 43 days with the average trade being worth of $114,372. The most recent stock trade was executed by Harlan Baird Radford on 28 June 2024, trading 87,064 units of ALLK stock currently worth $87,935.
What does Allakos Inc do?
allakos inc is a biotechnology company located in 7400 paseo padre pkwy, fremont, ca, united states.
What does Allakos Inc's logo look like?
Complete history of Adam Tomasi stock trades at Allakos Inc
Allakos Inc executives and stock owners
Allakos Inc executives and other stock owners filed with the SEC include:
-
Robert Alexander,
Chief Executive Officer, Director -
Adam Tomasi,
President, Chief Operating Officer -
Henrik Rasmussen,
Chief Medical Officer -
Leo Redmond,
Chief Financial Officer -
Mark Asbury,
Chief Legal Officer and General Counsel -
Dr. Robert Alexander Ph.D.,
CEO & Director -
Dr. Adam L. Tomasi Ph.D.,
Pres & COO -
Dr. Henrik Sandvad Rasmussen,
Strategic Advisor -
Mark Asbury,
Chief Legal Officer & Gen. Counsel -
Daniel Janney,
Independent Chair of the Board -
Robert Andreatta,
Independent Director -
John McKearn,
Independent Director -
Paul Walker,
Independent Director -
Steven James,
Independent Director -
Dr. Craig Paterson M.D.,
Chief Medical Officer -
Alan Chang,
Director of Medical Affairs & Data Analytics -
Tim Varacek,
Chief Commercial Officer -
Dr. Sally D. Bolmer,
Sr. VP of Regulatory Affairs & Drug Devel. -
Dr. Ruby Casareno Ph.D.,
Sr. VP of Technical Operations -
Baird Radford III,
Chief Financial Officer -
Group, Llc Green Jeremy Red...,
-
Venture Fund Iii, L.P.River...,
-
Partners Viii, L.P.Alta Par...,
-
Neil Murray Hamilton Graham,
-
Amy L Ladd,
-
Dolca Thomas,
-
Partners Next Gen Fund I Ma...,
-
Peter A Hudson,
-
Robert J More,
-
Guy P Nohra,
10% owner -
Natalie C. Holles,
Director -
Partners Next Gen Fund I Ma...,
-
Margaret Nell Fitzgerald,
General Counsel and Secretary -
Craig A. Paterson,
Chief Medical Officer -
Everett Rand Sutherland,
Director -
Partners Management Viii, L...,
-
Chin Hyok Lee,
Chief Medical Officer -
Harlan Baird Radford,
Chief Financial Officer